Safety, Pharmacokinetics, and Pharmacodynamics of MK-8876 in Participants With Hepatitis C Infection (MK-8876-003)
Clinical trial NCT01930058 · COMPLETED
Trial details
- NCT number
- NCT01930058
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2013-10-02
- Primary completion
- 2014-05-05
- Enrollment
- 9
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.